Immediate Impact
1 from Science/Nature 50 standout
Citing Papers
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Novel strategies to manage CAR-T cell toxicity
2025 Standout
Works of Tatsuro Jo being referenced
Mogamulizumab for relapsed adult T‐cell leukemia–lymphoma: Updated follow‐up analysis of phase I and II studies
2017
Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia/Lymphoma: ATLL-002
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tatsuro Jo | 220 | 140 | 26 | 110 | 25 | 274 | |
| Masaharu Miyahara | 164 | 80 | 69 | 60 | 31 | 306 | |
| Toshimasa Kukita | 203 | 109 | 63 | 89 | 29 | 330 | |
| M Iwahashi | 226 | 74 | 18 | 88 | 33 | 331 | |
| Shouhei INOUE | 101 | 75 | 3 | 58 | 41 | 289 | |
| Ashish Jain | 195 | 40 | 22 | 25 | 27 | 333 | |
| Junya Makiyama | 112 | 55 | 27 | 50 | 19 | 181 | |
| Koichi Nakase | 99 | 29 | 71 | 21 | 25 | 285 | |
| M Tara | 288 | 175 | 18 | 201 | 15 | 315 | |
| Yuhei Kamada | 84 | 32 | 55 | 29 | 15 | 192 | |
| Yuma Sakamoto | 54 | 29 | 31 | 18 | 28 | 189 |
All Works
Login with ORCID to disown or claim papers
Loading papers...